Specific Objective 5

Deployment: accelerating best use of technologies

About this programme

About the programme

The roll-out and best use of digital capacities focuses on priority areas such as the Green Deal, support to SMEs and public authorities in their digital transformation and will also provide resources to those activities started in previous programmes, for which the continuations of funding is essential not to disrupt the services provided.

Areas of activities include:

  • The deployment and enhancement of the European Blockchain Services Infrastructure (EBSI) set up in the context of CEF Telecommunications Programme (2014-2020), deployment of use cases as well as a regulatory sandbox for Blockchain standardisation.
  • The deployment of public services, including the digitalisation of governments and public administrations, focusing on preparing a European Identity and Trust Ecosystem, leveraging public procurement for digitalisation and innovation, enhancing the interoperability of public services, and the digital transformation of justice.
  • Confidence in digital transformation, including initiatives to make the internet a safer environment for children, addressing disinformation in the media, and accelerating energy transition.
Click to read more 
Hide text 

Your NCP contact for this programme

Image of Marie Timmermann

Marie Timmermann

marie.timmermann@fwo.be

+32 2 550 15 59

Your PC contact for this programme

Find the contact info on the site of WEWIS

The National Contact Points (NCPs) provide support, guidance, and practical information to potential applicants, helping them navigate funding opportunities and application processes.

The Programme Committee (PC) members represent their country in decision-making about the work programmes, evaluate implementation, and provide strategic input on priorities and calls.

Latest news

Related links

Related links are easy pointers towards external information. We curate the list, but are not liable for the destinations.

Documents

Documents contain additional information related to this programme, and are similar to related links.

    No documents available for this domain

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.